By Isaiah Webster III, Senior Manager, Health Equity/Prevention, NASTAD
Cross-posted from HRC.org
Source: Centers for Disease Control and Prevention (CDC)
National Gay Men’s HIV/AIDS Awareness Day is September 27. It’s an opportunity to reflect on those we have lost, and focus attention on the fact that HIV still impacts the lives of gay men more than any other group in the United States.
Just like any other social disease, HIV/AIDS takes advantage of those who lack access to information, prevention tools and medical advances that are readily available. The epidemic began as a crisis for all gay men, but in the last 15 years, it has shifted to become a disproportionate burden for certain subgroups of gay men–especially Black and Latino gay men, less affluent gay men, and gay men who live in rural communities. Among young gay men of color, the HIV/AIDS epidemic is as severe as it’s ever been.
By Ann Lefert, National Alliance of State and Territorial AIDS Directors and Bill McColl, AIDS United, Co-Chairs of the Ryan White Work Group, Federal AIDS Policy Partnership
As Co-Chairs of the Ryan White Work Group, we wanted to provide you with an update on the Ryan White Program. As you know, the current authorization ends on September 30, 2013. However, there is no “sunset” provision in the legislation. Therefore even if Congress does not take action, the Ryan White Program will remain a part of the law allowing funding to continue to be appropriated through the annual congressional appropriations process. Continue reading
By Meico Whitlock, Senior Manager, Communications
Every year since 1988, the National Minority AIDS Council (NMAC) has convened the annual United States Conference on AIDS (USCA). USCA brings together service providers, healthcare professionals, advocates, people living with HIV/AIDS, and policymakers.
This year, conference will be hosted in New Orleans, Louisiana and the focus will be on two major themes: the impact of the Affordable Care Act (ACA) on people living with HIV/AIDS (PLWHAs) and the need to improve the continuum of HIV care. The conference will also devote special attention to HIV/AIDS in the southern region of the U.S. Continue reading
FOR IMMEDIATE RELEASE
Contact: Meico Whitlock
August 26, 2013, Washington, DC – The ADAP Crisis Task Force (ACTF) has reached a new pricing agreement with ViiV Healthcare for AIDS Drug Assistance Programs (ADAPs) for Tivicay® (dolutegravir) for the treatment of HIV-1 infected individuals. The agreed-upon ADAP direct purchase price for Tivicay®, negotiated between the ACTF and ViiV, is substantially lower than the wholesale acquisition cost (WAC), reflecting voluntary discounts that are also significantly below the mandated 340B pricing of the medication.